{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-076841","form_type":"8-K","ticker":"TLSI","cik":"0001826667","company_name":"TriSalus Life Sciences, Inc.","filed_at":"2024-07-01T23:59:59+00:00","discovered_at":"2026-05-14T18:03:14.739401+00:00","generated_at":"2026-06-01T00:08:24.780375+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"TriSalus Life Sciences completes warrant exchange, issues 2.1M shares at 0.3 per warrant","bullets":["Issued 2,110,366 shares of common stock in exchange for tendered warrants at a ratio of 0.3 shares per warrant.","Exchange covered public warrants (TLSIW), private placement warrants, and working capital warrants.","Warrant agreement amended with Continental Stock Transfer effective June 26, 2024.","Offer and consent solicitation closed July 1, 2024; Oppenheimer served as dealer manager."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-076841","json":"https://secwatch.observer/filing/0001104659-24-076841.json","markdown":"https://secwatch.observer/filing/0001104659-24-076841.md","text":"https://secwatch.observer/filing/0001104659-24-076841.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1826667/000110465924076841/0001104659-24-076841-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1826667/000110465924076841/tm2418573d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T00:08:24.780375+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}